The Underlying Mechanism Involved in Gefitinib Resistance and Corresponding Experiment Validation in Lung Cancer.
Journal Information
Full Title: Mediators Inflamm
Abbreviation: Mediators Inflamm
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Conflicts of Interest The authors declare no conflicts of interest."
Funding Disclosure
Evidence found in paper:
"This study was supported by the Excellent Subject Reserve Talents Plan of Tongji Hospital Affiliated to Tongji University (HBRC1907) and the Clinical Research Project of Tongji Hospital of Tongji University (Grant No. ITJ(QN)2214)."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025